The Greater New Orleans Coagulation Conference (TGNOCC 2012) is the 7TH Symposium sponsored by Louisiana Coagulation Laboratory, Inc. The conference is designed to provide a base network for medical professionals who are interested in the diagnosis, treatment, and management of patients with bleeding and clotting disorders. This educational forum will feature lectures, presentations, discussions, and the opportunity to interact with providers of the equipment, reagents, and pharmaceutical products associated with the quality care of these patients.

Participants will:

o Get the latest information related to clinical and practical skills. 

o Enjoy a pleasant and informative atmosphere while networking and meeting with professionals in various areas of interest related to hemostasis.

o See state of the art technology in use by laboratories.

o Earn CME and/or PACE® credits


Program Objectives

Upon completing this conference, attendees should be able to:

1. List new drugs cleared by the FDA for use as anticoagulants.

2. Understand the impact of new anticoagulant drugs on coagulation test systems.

3. Understand how malignancies can initiate thrombotic events.

4. Know the basis of hemostatic problems which occur during certain chronic anemias.

5. Outline problems associated with treating thrombosis in the pediatric population.

6. Recognize patients at risk for acquired inhibitors.

7. Outline the clinical use of fibrinolytic agents.

8. Understand the best and latest procedures used for antiphospholipid syndrome.

9. Review clinical presentation and diagnosis of rare coagulation disorders.

Target Audience

This Program is intended for family physicians, oncologists, internists, pathologists, hematologists, pulmonologists, critical care physicians, obstetricians, gynecologists, nephrologists, cardiologists, neurologists, vascular surgeons, nurses, laboratory technologists, pharmacists, and other interested healthcare professionals who want to have a better understanding of hemostatic problems and the management problems related to these disorders.

The Vendors and Exhibitors will represent the laboratory industry as well as support industries and pharmaceuticals with an interest in enhancing the education of hemostatic disorders.